|
US6913751B2
(en)
|
1992-06-12 |
2005-07-05 |
Schering-Plough Veterinary Corporation |
Recombinant avian herpesvirus useful in vaccine production
|
|
WO1999018215A1
(en)
|
1997-10-03 |
1999-04-15 |
Nippon Zeon Co., Ltd. |
Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
|
|
AR031405A1
(es)
*
|
2000-11-21 |
2003-09-24 |
Wyeth Corp |
Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
|
|
JP2002356441A
(ja)
*
|
2001-03-15 |
2002-12-13 |
Akzo Nobel Nv |
組換え伝染性喉頭気管炎ウイルスワクチン
|
|
US7314715B2
(en)
*
|
2001-06-14 |
2008-01-01 |
Schering-Plough Animal Health Corporation |
Recombinant avian herpesvirus useful in vaccine production
|
|
US20030157641A1
(en)
*
|
2001-11-16 |
2003-08-21 |
Idec Pharmaceuticals Corporation |
Polycistronic expression of antibodies
|
|
IL161988A0
(en)
|
2001-11-16 |
2005-11-20 |
Corporation Idec Pharmaceutica |
Polycistronic expression of antibodies
|
|
EP1606419A1
(en)
|
2003-03-18 |
2005-12-21 |
Quantum Genetics Ireland Limited |
Systems and methods for improving protein and milk production of dairy herds
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
WO2005049794A2
(en)
|
2003-11-13 |
2005-06-02 |
University Of Georgia Research Foundation, Inc. |
Methods of characterizing infectious bursal disease virus
|
|
EP1718770B1
(en)
|
2004-02-19 |
2011-05-25 |
The Governors of the University of Alberta |
Leptin promoter polymorphisms and uses thereof
|
|
RS51324B
(sr)
|
2005-04-25 |
2010-12-31 |
Merial Ltd. |
Vakcine protiv nipah virusa
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
EP3147296A1
(en)
|
2005-11-14 |
2017-03-29 |
Merial, Inc. |
Gene therapy for renal failure
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
MX347997B
(es)
|
2009-04-03 |
2017-05-22 |
Merial Ltd |
Vacunas aviares vectorizadas con el virus de la enfermedad de newcastle.
|
|
ATE539148T1
(de)
|
2009-11-30 |
2012-01-15 |
United Cancer Res Inst |
Neuer klon des geflügelpestvirus, herstellung und anwendung bei der medizinischen behandlung von krebs
|
|
WO2011090708A2
(en)
|
2009-12-28 |
2011-07-28 |
Merial Limited |
Recombinant ndv antigen and uses thereof
|
|
US20130129780A1
(en)
*
|
2010-08-02 |
2013-05-23 |
University Of Georgia Research Foundation, Inc. |
Modified infectious laryngotracheitis virus (iltv) and uses thereof
|
|
PL2611460T3
(pl)
|
2010-08-31 |
2017-02-28 |
Merial, Inc. |
Szczepionki przeciw herpeswirusom przenoszone z pomocą wirusa choroby newcastle
|
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
|
US20140296248A1
(en)
|
2011-04-04 |
2014-10-02 |
Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis |
Methods and compositions for predicting resistance to anticancer treatment
|
|
US20140287931A1
(en)
|
2011-04-04 |
2014-09-25 |
Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis |
Methods and compositions for predicting resistance to anticancer treatment
|
|
US9216213B2
(en)
|
2011-04-20 |
2015-12-22 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
CN103945864A
(zh)
|
2011-04-25 |
2014-07-23 |
先进生物学实验室股份有限公司 |
截短的hiv包膜蛋白(env)、其相关方法和组合物
|
|
ES2674439T3
(es)
|
2011-06-01 |
2018-06-29 |
Merial, Inc. |
Administración sin aguja de vacunas contra el VSRRP
|
|
WO2013025274A1
(en)
|
2011-08-12 |
2013-02-21 |
Merial Limited |
Vacuum -assisted preservation of biological products, in particular of vaccines
|
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
|
WO2013138776A1
(en)
|
2012-03-16 |
2013-09-19 |
Merial Limited |
Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
|
|
US10709341B2
(en)
|
2012-11-21 |
2020-07-14 |
St. Jude Medical Luxembourg Holdings II S.a.r.l. |
Devices, systems, and methods for pulmonary arterial hypertension (PAH) assessment and treatment
|
|
WO2014164697A1
(en)
|
2013-03-12 |
2014-10-09 |
Merial Limited |
Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
|
|
US9198908B2
(en)
|
2013-03-15 |
2015-12-01 |
St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux Ii”) |
Methods for the treatment of cardiovascular conditions
|
|
EP2845904A1
(en)
*
|
2013-09-06 |
2015-03-11 |
Ceva Sante Animale |
Recombinant Marek's disease viruses and uses thereof
|
|
AU2015343369B2
(en)
|
2014-11-03 |
2018-11-22 |
Georgia Tech Research Corporation |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
ES3050936T3
(en)
|
2015-06-23 |
2025-12-23 |
Boehringer Ingelheim Vetmedica Gmbh |
Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
|